Crispr Therapeutics Ag (CRSP) Stock Price, Quote & News

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 41 561 32 77

Website: www.crisprtx.com

Address:

Baarerstrasse 14, Zug, Switzerland

Billonstart Jan. 5 at 2:08 AM

$CRSP Even if you are afraid, now is the time to be courageous.

0 · Reply

WallStreetBuyDip Jan. 5 at 12:27 AM

$REGN trading at $776, while $CRSP at $54. REGN down 57% on volume compared to average, CRSP down 45%. Healthcare sector vibes - which gene-editing player has the potential to bounce back stronger with increased volume? 🧬

0 · Reply

jeojackson Jan. 4 at 10:14 PM

$PRME $NTLA $CRSP Artificial Intelligence will pretty much eliminate work for the majority of humans. Whats left is extension of human life - thats pretty much it. Its biotech baby!

1 · Reply

MoneyGroupLLC Jan. 4 at 7:10 PM

Enter: $CRSP Calls Strike Price: $55 Expiry Date: JAN 30 2026 Buy in Price: $2.80 - $3.10 Sell Price: $4.79 Profit : +71% (Turn every $1 into $1.71) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/

0 · Reply

Joethenovice Jan. 4 at 1:01 AM

$CRSP If you realize what their cholesterol breakthrough means and how soon it can change the world...you understand why the director loaded up.

0 · Reply

BillyBlanks77 Jan. 2 at 8:40 PM

$CRSP The shorts are the Russians...

0 · Reply

boston_drew Jan. 2 at 8:25 PM

$CRSP Seems like news is maybe leaking

1 · Reply

dios89 Jan. 2 at 8:21 PM

$CRSP thats a lot of buying.

0 · Reply

boston_drew Jan. 2 at 8:07 PM

$CRSP someone is buying into the close

0 · Reply

cat_from_the_future Jan. 2 at 6:49 PM

$CRSP slow bleed every day is frustrating to watch...looking back at the last 10 days it's the same exact pattern every day, open with some strength then bleed out all day long.

0 · Reply

Crispr Therapeutics: Prospects For 2026 - Why I Believe Casgevy Is Key

Dec 31, 2025, 5:06 PM EST - 4 days ago

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

Dec 22, 2025, 12:45 PM EST - 13 days ago

CRISPR Therapeutics CRISPR Therapy Shows 90% Response Rate In Aggressive Blood Cancer

Dec 22, 2025, 8:30 AM EST - 13 days ago

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies

Dec 4, 2025, 10:29 AM EST - 4 weeks ago

Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy

Nov 13, 2025, 3:43 PM EST - 7 weeks ago

CRISPR Therapeutics Post Q3 Earnings: Testing Investor Patience, But Still A Buy

Nov 10, 2025, 8:00 AM EST - 7 weeks ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 8, 2025, 10:03 AM EST - 2 months ago

CRISPR gene therapy slashes 'bad' cholesterol, triglycerides by half in small study

Nov 8, 2025, 9:56 AM EST - 2 months ago

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

Oct 10, 2025, 8:00 AM EDT - 3 months ago

CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform

Oct 1, 2025, 8:00 AM EDT - 3 months ago

CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

Sep 17, 2025, 4:09 PM EDT - 3 months ago

Crispr Therapeutics: Why Stock Fell On Q2 Earnings, And Why We're Now Back On Track

Sep 9, 2025, 4:00 PM EDT - 4 months ago

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

Sep 9, 2025, 2:22 PM EDT - 4 months ago

Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade.

INCY XBI XLV

Sep 9, 2025, 11:38 AM EDT - 4 months ago

CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 6:53 AM EDT - 4 months ago

CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference Transcript

Sep 2, 2025, 8:55 AM EDT - 4 months ago

Crispr Therapeutics: A Winning Lottery Ticket Doesn't Replace Grand Strategy

Sep 2, 2025, 8:00 AM EDT - 4 months ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Aug 27, 2025, 6:21 AM EDT - 4 months ago

Crispr Therapeutics: A Speculative Buy With Promising Potential Ahead

Aug 14, 2025, 1:02 PM EDT - 5 months ago

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

AMD ARKF ARKG ARKK ARKQ ARKW ARKX

Aug 14, 2025, 7:27 AM EDT - 5 months ago

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

Aug 4, 2025, 4:15 PM EDT - 5 months ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Jul 23, 2025, 11:03 AM EDT - 5 months ago

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

Jul 15, 2025, 12:01 PM EDT - 6 months ago

The Big 3: ASML, GOOGL, CRSP

ASML GOOG GOOGL

Jul 14, 2025, 8:00 AM EDT - 6 months ago

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

Jun 26, 2025, 7:00 AM EDT - 6 months ago

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Jun 23, 2025, 12:01 PM EDT - 6 months ago

The Big 3: CRSP, OKLO, GME

OKLO GME

Jun 13, 2025, 6:27 PM EDT - 7 months ago

Crispr Therapeutics: Betting On A One-Shot Future

Jun 9, 2025, 5:50 PM EDT - 7 months ago

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Jun 3, 2025, 4:07 PM EDT - 7 months ago

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

May 9, 2025, 7:14 AM EDT - 8 months ago

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

May 8, 2025, 8:36 AM EDT - 8 months ago

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

May 7, 2025, 4:03 PM EDT - 8 months ago

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

May 7, 2025, 2:17 PM EDT - 8 months ago

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

May 7, 2025, 8:39 AM EDT - 8 months ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

May 6, 2025, 4:01 PM EDT - 8 months ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

May 5, 2025, 4:44 AM EDT - 8 months ago

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

NTLA

Apr 8, 2025, 3:29 PM EDT - 9 months ago

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

Apr 3, 2025, 8:00 AM EDT - 9 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 4:01 PM EDT - 10 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Mar 25, 2025, 11:03 AM EDT - 10 months ago

CRISPR Therapeutics Set To Reach Previous Heights

Mar 3, 2025, 3:28 PM EST - 10 months ago

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

Feb 26, 2025, 8:00 AM EST - 11 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 13, 2025, 11:06 AM EST - 11 months ago

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

Feb 11, 2025, 4:01 PM EST - 11 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 5, 2025, 4:16 PM EST - 11 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Feb 5, 2025, 3:48 PM EST - 11 months ago

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Jan 15, 2025, 7:20 PM EST - 1 year ago

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

Jan 14, 2025, 7:39 PM EST - 1 year ago

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 8, 2025, 8:30 AM EST - 1 year ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Billonstart Jan. 5 at 2:08 AM

$CRSP Even if you are afraid, now is the time to be courageous.

0 · Reply

WallStreetBuyDip Jan. 5 at 12:27 AM

0 · Reply

jeojackson Jan. 4 at 10:14 PM

$PRME $NTLA $CRSP Artificial Intelligence will pretty much eliminate work for the majority of humans. Whats left is extension of human life - thats pretty much it. Its biotech baby!

1 · Reply

MoneyGroupLLC Jan. 4 at 7:10 PM

0 · Reply

Joethenovice Jan. 4 at 1:01 AM

$CRSP If you realize what their cholesterol breakthrough means and how soon it can change the world...you understand why the director loaded up.

0 · Reply

BillyBlanks77 Jan. 2 at 8:40 PM

$CRSP The shorts are the Russians...

0 · Reply

boston_drew Jan. 2 at 8:25 PM

$CRSP Seems like news is maybe leaking

1 · Reply

dios89 Jan. 2 at 8:21 PM

$CRSP thats a lot of buying.

0 · Reply

boston_drew Jan. 2 at 8:07 PM

$CRSP someone is buying into the close

0 · Reply

cat_from_the_future Jan. 2 at 6:49 PM

$CRSP slow bleed every day is frustrating to watch...looking back at the last 10 days it's the same exact pattern every day, open with some strength then bleed out all day long.

0 · Reply

Etrading Jan. 2 at 5:15 PM

V time added $AVGO $BRK.B $CRSP $DXYZ $SPY

0 · Reply

Awiz2 Jan. 2 at 3:52 PM

$CRSP This is our breakout year!!!

0 · Reply

Etrading Jan. 2 at 2:51 PM

Sold my $QQQ put hedge ; LOADED MORE $CRSP $BULL $RXRX $SPY

0 · Reply

BillyBlanks77 Jan. 2 at 2:42 PM

$CRSP this is the year for gene editing and CRSP. Expect upgrades and consolidation. Been a long timing coming.

0 · Reply

burbs88 Jan. 2 at 1:52 PM

$CRSP Christ alive, how many accounts do I have to block? Worse than my email

0 · Reply

MoneyGroupLLC Jan. 2 at 1:12 PM

Enter: $CRSP Calls Strike Price: $53 Expiry Date: JAN 23 2026 Buy in Price: $4.00 - $4.70 Sell Price: $7.88 Profit : +97% (Turn every $1 into $1.97) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

N0Bounds Jan. 2 at 10:55 AM

$BITF $TE $CRSP $BTBT $UPST 4

0 · Reply

N0Bounds Jan. 2 at 9:20 AM

$BA $BTBT $CRSP $NEE $HYMC c

0 · Reply

ZendayasSaltyBALLS Jan. 2 at 4:42 AM

$CRSP

0 · Reply

Market Cap	5.12B
Revenue (ttm)	37.31M
Net Income (ttm)	-366.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-981.64%
Debt to Equity Ratio	0.00

Volume	1,373,100
Avg Vol	2,087,894
Day's Range	N/A - N/A
Shares Out	95.30M
Stochastic %K	24%
Beta	1.70
Analysts	Strong Sell
Price Target	$80.54